Free Trial

Protagonist Therapeutics (PTGX) Institutional Ownership

Protagonist Therapeutics logo
$138.69 -1.94 (-1.38%)
Closing price 04:00 PM Eastern
Extended Trading
$138.71 +0.02 (+0.01%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Protagonist Therapeutics (NASDAQ:PTGX)

Current
Institutional Ownership
Percentage
98.63%
Number of
Institutional Buyers
(last 12 months)
204
Total
Institutional Inflows
(last 12 months)
$3.80B
Number of
Institutional Sellers
(last 12 months)
115
Total
Institutional Outflows
(last 12 months)
$610.36M
Get PTGX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Protagonist Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

PTGX Institutional Buying and Selling by Quarter

Protagonist Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026Tidal Investments LLC4,988$611K0.0%-54.8%0.008%
9/9/2026WINTON GROUP Ltd10,884$1.33M0.0%-14.1%0.017%
9/9/2026Engineers Gate Manager LP4,373$536K0.0%N/A0.007%
9/8/2026Arizona State Retirement System14,085$1.73M0.0%+2.5%0.022%
9/8/2026Nykredit A S2,415$296K0.0%N/A0.004%
8/26/2026Amundi7,692$943K0.0%+87.0%0.012%
8/26/2026HighTower Advisors LLC5,308$651K0.0%-1.4%0.008%
8/25/2026VIRGINIA RETIREMENT SYSTEMS ET Al11,200$1.37M0.0%N/A0.017%
8/22/2026Concurrent Investment Advisors LLC1,926$236K0.0%-6.5%0.003%
8/21/2026AXQ Capital LP2,138$262K0.0%N/A0.003%
8/20/2026Alyeska Investment Group L.P.889,298$109.01M0.3%+49.9%1.374%
8/20/2026Northwestern Mutual Wealth Management Co.48,894$5.99M0.0%-0.3%0.076%
8/19/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC107,094$13.13M0.0%-0.3%0.165%
8/19/2026Hsbc Holdings PLC25,952$3.20M0.0%+1,260.9%0.040%
8/19/2026Wellington Management Group LLP3,416,781$418.83M0.1%-5.1%5.280%
8/18/2026Twin Lakes Capital Management LLC58,059$7.12M2.7%N/A0.090%
8/18/2026Empowered Funds LLC2,264$278K0.0%N/A0.003%
8/17/2026Seven Fleet Capital Management LP45,400$5.57M0.9%+1,035.0%0.070%
8/17/2026Artia Global Partners LP22,951$2.81M0.5%N/A0.035%
8/17/2026Bamco Inc. NY16,000$1.96M0.0%N/A0.025%
8/17/2026Bank of America Corp DE1,324,498$162.36M0.0%N/A2.047%
8/15/2026Jupiter Topco LLC2,129,780$261.04M0.1%N/A3.291%
8/15/2026Elmind Capital LP38,000$4.66M0.0%N/A0.059%
8/15/2026J. Goldman & Co LP9,414$1.15M0.0%N/A0.015%
8/14/2026ADAR1 Capital Management LLC960,863$117.78M5.4%N/A1.485%
8/14/2026Hsbc Holdings PLC25,952$3.20M0.0%N/A0.040%
8/14/2026EFG International AG40,501$4.96M0.1%N/A0.063%
8/14/2026Castleark Management LLC50,570$6.20M0.2%N/A0.078%
8/14/2026Legal & General Group Plc132,351$16.22M0.0%N/A0.205%
8/14/2026The Manufacturers Life Insurance Company108,555$13.31M0.0%N/A0.168%
8/14/2026Algert Global LLC87,698$10.75M0.1%+11.8%0.136%
8/13/2026Connor Clark & Lunn Investment Management Ltd.29,161$3.58M0.0%N/A0.045%
8/12/2026Elevation Point Wealth Partners LLC2,369$290K0.0%N/A0.004%
8/12/2026Northwestern Mutual Wealth Management Co.48,894$5.99M0.0%N/A0.076%
8/12/2026Quantbot Technologies LP342$42K0.0%N/A0.001%
8/11/2026Keating Financial Advisory Services Inc.242$30K0.0%N/A0.000%
8/11/2026Allworth Financial LP254$31K0.0%N/A0.000%
8/11/2026E Fund Management Co. Ltd.3,891$477K0.0%N/A0.006%
8/10/2026Eagle Health Investments LP248,322$30.44M5.0%N/A0.386%
8/10/2026Great Lakes Advisors LLC56,904$6.98M0.1%N/A0.088%
Your book is inside (Ad)

Stop one bad trade from turning into a bad week. The free report How To Stop Revenge Trading in 5 Steps lays out the exact rules used to break the cycle before it starts. It normally sells for $29.97, but it is currently available at no cost.tc pixel

Download your free revenge trading report now
8/7/2026BlackRock Inc.10,307,837$1.26B0.0%N/A16.028%
8/7/2026Deutsche Bank AG141,838$17.39M0.0%N/A0.221%
8/6/2026Global Retirement Partners LLC1,055$129K0.0%N/A0.002%
8/6/2026Bank of New York Mellon Corp358,300$43.92M0.0%N/A0.557%
8/6/2026State of Wyoming3,102$380K0.0%N/A0.005%
8/6/2026Johnson & Johnson2,449,183$300.22M0.0%N/A3.808%
7/10/2026Handelsbanken Fonder AB21,400$2.62M0.0%+7.5%0.033%
7/9/2026Franklin Street Advisors Inc. NC12,810$1.57M0.1%+15.6%0.020%
7/7/2026GAMMA Investing LLC3,109$381K0.0%+7.2%0.005%
7/7/2026Harbor Investment Advisory LLC724$89K0.0%N/A0.001%
6/18/2026Pacer Advisors Inc.4,916$518K0.0%N/A0.008%
6/16/2026Empowered Funds LLC2,321$245K0.0%N/A0.004%
6/4/2026Seven Fleet Capital Management LP4,000$422K0.1%-50.0%0.006%
5/29/2026Perceptive Advisors LLC1,230,879$129.74M2.5%-8.9%1.914%
5/26/2026Glenmede Trust Co. NA9,235$973K0.0%-27.6%0.014%
5/26/2026Axiom Investment Management LLC2,000$211K0.2%N/A0.003%
5/22/2026Segall Bryant & Hamill LLC212,714$22.42M0.3%+64.8%0.331%
5/19/2026Bank of America Corp DE1,295,434$136.54M0.0%+49.3%2.014%
5/19/2026Stempoint Capital LP72,577$7.65M1.5%+22.1%0.113%
5/19/2026Janus Henderson Group PLC2,891,527$304.87M0.1%+9.1%4.496%
5/18/2026ADAR1 Capital Management LLC994,119$104.78M6.2%-5.2%1.546%
5/18/2026Amundi4,113$434K0.0%N/A0.006%
5/18/2026EverSource Wealth Advisors LLC911$96K0.0%+63.0%0.001%
5/18/2026California State Teachers Retirement System58,677$6.19M0.0%+22.2%0.091%
5/18/2026Royal Bank of Canada1,599$169K0.0%-49.8%0.002%
5/18/2026Rubric Capital Management LP427,998$45.11M0.5%N/A0.666%
5/18/2026Eagle Health Investments LP179,322$18.90M3.3%+213.0%0.279%
5/18/2026Empowered Funds LLC2,321$245K0.0%N/A0.004%
5/16/2026The Manufacturers Life Insurance Company127,818$13.47M0.0%+12.8%0.199%
5/16/2026Quantinno Capital Management LP6,437$678K0.0%+30.1%0.010%
5/16/2026Orbimed Advisors LLC42,100$4.44M0.1%+94.0%0.065%
5/15/2026Weiss Asset Management LP9,780$1.03M0.0%N/A0.015%
5/15/2026Granahan Investment Management LLC27,391$2.89M0.1%N/A0.043%
5/14/2026Gabelli Funds LLC3,229$340K0.0%N/A0.005%
5/14/2026Atika Capital Management LLC62,100$6.55M0.8%-27.8%0.097%
5/14/2026Knott David M Jr63,000$6.64M3.9%-13.7%0.098%
5/14/2026Sei Investments Co.83,197$8.77M0.0%+122.8%0.129%
5/13/2026First Trust Advisors LP87,858$9.26M0.0%+89.1%0.137%
5/8/2026PNC Financial Services Group Inc.3,998$421K0.0%+35.1%0.006%
5/7/2026Dimensional Fund Advisors LP508,103$53.54M0.0%+22.6%0.790%
5/7/2026AlphaCentric Advisors LLC9,040$953K1.0%+5.7%0.014%
5/7/2026SEB Asset Management AB232,416$24.50M0.1%N/A0.361%
5/7/2026Swiss National Bank98,900$10.42M0.0%+0.7%0.154%
5/6/2026Jennison Associates LLC1,072,011$112.99M0.1%+223.7%1.667%
5/6/2026Assetmark Inc.46,442$4.90M0.0%+16,195.4%0.072%
5/6/2026Allspring Global Investments Holdings LLC29,916$3.10M0.0%+650.7%0.047%
5/5/2026Bank of New York Mellon Corp341,465$35.99M0.0%-2.5%0.531%
5/5/2026Illinois Municipal Retirement Fund28,596$3.01M0.0%-8.5%0.044%
5/4/2026Calamos Advisors LLC23,473$2.47M0.0%N/A0.036%
5/4/2026Bleakley Financial Group LLC12,802$1.35M0.0%N/A0.020%
Do this before December or regret it (Ad)

Porter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monetary reset tied to executive order 14241 - one he says could draw a sharp dividing line between prepared investors and those left behind. The last time America reset its money - under Nixon in the 1970s - it produced an average of 1,300 new millionaires per day for over 50 years. Stansberry's new documentary names a core group of assets he believes are positioned to surge as Trump's new dollar rolls out. Watch Porter Stansberry's full briefing and get his three steps to prepare before December.tc pixel

Watch Porter Stansberry's full briefing and get his three steps to prepare before December.
5/4/2026Principal Financial Group Inc.367,822$38.77M0.0%+5.7%0.572%
5/1/2026Fifth Third Bancorp13,202$1.39M0.0%+3,937.3%0.021%
4/30/2026Hsbc Holdings PLC1,907$201K0.0%N/A0.003%
4/30/2026Sumitomo Mitsui Trust Group Inc.2,760$291K0.0%+7.8%0.004%
4/29/2026Burney Co.3,179$335K0.0%-13.6%0.005%
4/28/2026Abel Hall LLC4,258$449K0.1%N/A0.007%
4/27/2026New York State Teachers Retirement System47,424$5.00M0.0%-3.9%0.074%
4/25/2026Strs Ohio15,400$1.62M0.0%-3.1%0.024%
4/25/2026Keybank National Association OH4,286$452K0.0%N/A0.007%
4/23/2026Inspire Investing LLC5,036$531K0.0%-7.8%0.008%


PTGX Institutional Ownership - Frequently Asked Questions

During the previous two years, 353 institutional investors and hedge funds held shares of Protagonist Therapeutics. The most heavily invested institutionals were BlackRock Inc. ($1.26B), Farallon Capital Management LLC ($536.62M), Vanguard Group Inc. ($472.83M), RTW Investments LP ($441.86M), Wellington Management Group LLP ($418.83M), Janus Henderson Group PLC ($304.87M), and Johnson & Johnson ($300.22M).Learn more on Protagonist Therapeutics' institutional investors.

98.63% of Protagonist Therapeutics' stock is owned by institutional investors. Learn more on PTGX's institutional investor holdings.

Of the 319 institutional investors that purchased Protagonist Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($10.31M), Wellington Management Group LLP ($4.03M), Johnson & Johnson ($2.45M), Jupiter Topco LLC ($2.13M), Bank of America Corp DE ($2.10M), Pacer Advisors Inc. ($1.88M), and Janus Henderson Group PLC ($1.79M).

Institutional investors have bought a total of 36,427,848 shares in the last 24 months. This purchase volume represents approximately $3.80B in transactions.

Of the 115 institutional investors that sold Protagonist Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Deep Track Capital LP ($1.53M), Jefferies Financial Group Inc. ($819.02K), RTW Investments LP ($697.22K), Commodore Capital LP ($625K), UBS Group AG ($605.24K), Adage Capital Partners GP L.L.C. ($485.37K), and JPMorgan Chase & Co. ($471.68K).

Institutional investors have sold a total of 7,718,805 shares in the last 24 months. This volume of shares sold represents approximately $610.36M in transactions.



Institutional ownership data for NASDAQ:PTGX is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.
From Our Partners